Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE)
Stroke · 2023-06 · 54 (6) · 1494-1504
DOI: 10.1161/strokeaha.122.041932 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Stroke, 2023-06. Verfasst von Satoshi Kuroda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan (S.K., S.Y., E.H.). Hauptthemen laut MEDLINE: Moyamoya Disease, Hemorrhagic Stroke, Stroke. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Long-term outcomes are unknown in patients with asymptomatic moyamoya disease. In this report, we aimed to clarify their 5-year risk of stroke and its predictors.
Methods
We are conducting a multicenter, prospective cohort study (Asymptomatic Moyamoya Registry) in Japan. Participants were eligible if they were 20 to 70 years, had bilateral or unilateral moyamoya disease, experienced no episodes suggestive of TIA and stroke; and were functionally independent (modified Rankin Scale score 0–1). Demographic and radiological information was collected at enrollment. In this study, they are still followed up for 10 years. In this interim analysis, we defined the primary end point as a stroke occurring during a 5-year follow-up period. Independent predictors for stroke were also determined, using a stratification analysis method.
Results
Between 2012 and 2015, we enrolled 109 patients, of whom 103 patients with 182 involved hemispheres completed the 5-year follow-up. According to the findings on DSA and MRA, 143 hemispheres were judged as moyamoya disease and 39 hemispheres as questionable manifestations (isolated middle cerebral artery stenosis). The patients with questionable hemispheres were significantly older, more often male, and more frequently had hypertension than those with moyamoya hemisphere. Moyamoya hemispheres developed 7 strokes, including 6 hemorrhagic and 1 ischemic stroke, during the first 5 years. The annual risk of stroke was 1.4% per person, 0.8% per hemisphere, and 1.0% per moyamoya hemisphere. Independent predictor for stroke was Grade-2 choroidal anastomosis (hazard ratio, 5.05 [95% CI, 1.24–20.6]; P =0.023). Furthermore, microbleeds (hazard ratio, 4.89 [95% CI, 1.13-21.3]; P =0.0342) and Grade-2 choroidal anastomosis (hazard ratio, 7.05 [95% CI, 1.62–30.7]; P =0.0093) significantly predicted hemorrhagic stroke. No questionable hemispheres developed any stroke.
Conclusions
The hemispheres with asymptomatic moyamoya disease may carry a 1.0% annual risk of stroke during the first 5 years, the majority of which are hemorrhagic stroke. Grade-2 choroidal anastomosis may predict stroke, and the microbleeds and Grade-2 choroidal anastomosis may carry the risk for hemorrhagic stroke. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: UMIN000006640.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan (S.K., S.Y., E.H.).
- Department of Neurosurgery, Kyoto University Graduate School of Medicine, Japan (T.F., S.M.).
- Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan (M.F.).
- Department of Neurosurgery, National Cerebral and Cardiovascular Center, Suita, Japan (H.K.).
- Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Japan (T.H.).
- Department of Neurosurgery, Kindai University School of Medicine, Sayama, Japan (J.T.).
ORCID-Profile: Satoshi Kuroda, Takeshi Funaki, Miki Fujimura, Hiroharu Kataoka, Jun Takahashi, Hidenori Endo, Tadashi Nariai, Emiko Hori, Yoichi M Ito, Susumu Miyamoto
Zitieren
APA
Kuroda, S., Yamamoto, S., Funaki, T., Fujimura, M., Kataoka, H., Hishikawa, T., Takahashi, J., Endo, H., Nariai, T., Osato, T., Saito, N., Sato, N., Hori, E., Ito, Y. M., Miyamoto, S., & AMORE Study Group (2023). Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE). Stroke, 54(6), 1494-1504. https://doi.org/10.1161/strokeaha.122.041932
Vancouver
Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T, et al. Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE). Stroke. 2023;54(6):1494-1504. doi:10.1161/strokeaha.122.041932
BibTeX
@article{Kuroda2023,
author = {Kuroda, Satoshi and Yamamoto, Shusuke and Funaki, Takeshi and Fujimura, Miki and Kataoka, Hiroharu and Hishikawa, Tomohito and Takahashi, Jun and Endo, Hidenori and Nariai, Tadashi and Osato, Toshiaki and Saito, Nobuhito and Sato, Norihiro and Hori, Emiko and Ito, Yoichi M and Miyamoto, Susumu and AMORE Study Group, AMORE Study Group},
title = {Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE)},
journal = {Stroke},
year = {2023},
volume = {54},
number = {6},
pages = {1494--1504},
doi = {10.1161/strokeaha.122.041932}
}
EUVIMED